Comparing donor stem cell transplants for T-cell leukemia in remission
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This trial compares using your own stem cells versus a donor's stem cells for a transplant to treat T-lymphoblastic leukemia or lymphoma after you've reached first remission. The goal is to see which approach works better to keep the disease from coming back.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 14 and 55 years old.
- You have T-lymphoblastic leukemia or lymphoma that is in first complete remission after chemotherapy.
- Your cancer is not in your brain or spinal cord, or if it was, it's now under control.
- Your heart, liver, kidneys, and lungs are working well enough for a transplant.
- You have not had another cancer in the last 5 years, except for certain early-stage or cured cancers.
- You do not have an active infection or serious health problems that would make a transplant unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two types of stem cell transplants for adults with T-cell lymphoblastic lymphoma that has spread (stage III or IV) and has gone into remission after 3 rounds of chemo. The goal is to see which transplant approach works better.
This trial tests a stem cell transplant using a half-matched family donor for children with acute lymphoblastic leukemia (ALL) that is in remission. It compares two different types of radiation conditioning to prepare the body for the new cells, with the goal of improving outcomes.
This trial tests whether high-dose chemotherapy followed by a stem cell transplant using your own cells can help people with certain types of peripheral T-cell lymphoma live longer. You would qualify if you have already finished your first round of chemotherapy and are in complete remission.
This Phase 2 trial tests whether a specific stem cell transplant method (from a related “half-matched” donor) plus conditioning chemo and radiation can improve outcomes for several blood cancers. It may help people whose cancer is in remission but still considered high risk, or those who have had limited response after prior treatment.
This trial studies whether doing an autologous stem cell transplant (using your own stem cells) after a complete response helps people with certain T-cell lymphomas stay in remission longer. It may be an option if your lymphoma has shrunk completely and you fit the safety and testing requirements.
This Phase 2 study tests a specialized stem cell transplant that removes certain immune “T-cell” receptors to help treat blood cancers like acute leukemia. It may help your body rebuild a healthier immune system after high-dose treatment.
Hear when a new T Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.